United Nations Environment Assembly Touches Key Global Health Themes 11/03/2019 Elaine Ruth Fletcher The Fourth United Nations Environment Assembly (UNEA) opened today in Nairobi against the sober backdrop of yesterday’s tragic crash of Ethiopian Airlines flight 302 en route to the Kenyan capital, killing at least 22 UN staff and humanitarian aid workers, including passengers headed to the UNEA meeting. Image Credits: Baz Ratner/Reuters, @CCAC coalition. Continue reading -> Short Regimen For TB Found To Be Safe With New First-Line HIV Drug 07/03/2019 William New In what is being called an "important moment" for tuberculosis (TB) control, a new study found that "a shorter regimen to prevent TB can be safely co-administered with dolutegravir (DTG)—the first-line drug to treat HIV in many high-burden TB countries," according to a release. Continue reading -> WHO Announces “Most Wide-Ranging Reforms In Organization’s History” 06/03/2019 Editorial team Calling it a “historic moment,” World Health Organization Director General Tedros Adhanom Gheyebresus today announced wide-ranging reforms in the organization’s structure – claiming they would prove to be the most significant ones in WHO’s 71-year history. Continue reading -> African Heads Of State Endorse Continental Medicine Regulator 06/03/2019 Divya Schlesinger The African content is one step closer to its first medicine and health super-regulator. The treaty to establish an African Medicine Agency (AMA), meant to govern medical product regulation for the entire continent, was endorsed by the African Union Heads of State and Government on 11 February, according to a press release following the 32nd AU Summit in Addis Ababa, Ethiopia. Continue reading -> Mixed Global Progress On Use Of Antibiotics In Animals: OIE Report 01/03/2019 William New There continues to be positive progress on controlling the use of antimicrobials in animals in countries, according to a recent report of the World Organisation for Animal Health (OIE), which is linked to the rise in human antimicrobial resistance. But more countries need to take action and better data is needed from many, the report found, as efforts will continue. Continue reading -> WHO-Led Fair Pricing Forum Registration Opens 01/03/2019 William New Registration has begun for a closed-door gathering allowing governments and stakeholders to hold open discussions about a fairer pricing system for medical products, led by the World Health Organization. The second meeting of the Fair Pricing Forum, this time in South Africa, comes as debates over drug pricing and access rise ever higher in developing and developed countries alike. Continue reading -> Strengthening Supply Chain Security For Essential Antimalarial Drugs 28/02/2019 David Branigan Secure and reliable supply chains for life-saving medicines are essential features of the global health landscape. They ensure that quality approved drugs are manufactured and available in the quantities needed, without interruption. For the fight against malaria, securing supply chains for quality, life-saving antimalarials involves the collective effort of a range of organisations working to mitigate the risk of any shortage of these drugs. A recent success in this area has been the quality approval of a second supplier of injectable artesunate, the drug recommended by the World Health Organization to treat severe malaria. Continue reading -> UN Launches New Strategy On Road Safety For UN Personnel 28/02/2019 David Branigan The United Nations has launched a new road safety strategy to establish a coordinated approach for preventing road traffic crashes, which is a leading cause of death for UN personnel. Continue reading -> Médecins Sans Frontières On Drug Prices – You Can’t Negotiate Blindfolded 27/02/2019 Elaine Ruth Fletcher Katy Athersuch, Médecins Sans Frontières (MSF) Senior Policy Advisor – Medical Innovation & Access, spoke to Health Policy Watch about the recent proposal by Italy’s Minister of Health, Giulia Grillo, for a World Health Assembly resolution on transparency in drug pricing (Health Policy Watch 18 February). The far-reaching proposal asks countries to require disclosure by pharmaceutical companies of their R&D and, manufacturing costs, and public subsidies received, at the time a drug is registered. The resolution would also strengthen WHO’s role in global monitoring and assessment of available data on the costs and pricing of essential medicines. This is the first in a series of Q&As on the issue, looking towards April’s Fair Pricing Forum, where WHO member states will convene in South Africa, followed by the annual World Health Assembly in May. Continue reading -> Global Accelerator Network On Antibacterial Research Expands 26/02/2019 William New A network of life sciences organisations working together to address antibacterial resistance worldwide has expanded to now include 10 top organisations from six countries, according to CARB-X (Combating Antibiotic Resistant Bacteria), a US-based partnership investing hundreds of millions of dollars in R&D for antibacterial resistance over 5 years. Continue reading -> Posts navigation Older postsNewer posts
Short Regimen For TB Found To Be Safe With New First-Line HIV Drug 07/03/2019 William New In what is being called an "important moment" for tuberculosis (TB) control, a new study found that "a shorter regimen to prevent TB can be safely co-administered with dolutegravir (DTG)—the first-line drug to treat HIV in many high-burden TB countries," according to a release. Continue reading -> WHO Announces “Most Wide-Ranging Reforms In Organization’s History” 06/03/2019 Editorial team Calling it a “historic moment,” World Health Organization Director General Tedros Adhanom Gheyebresus today announced wide-ranging reforms in the organization’s structure – claiming they would prove to be the most significant ones in WHO’s 71-year history. Continue reading -> African Heads Of State Endorse Continental Medicine Regulator 06/03/2019 Divya Schlesinger The African content is one step closer to its first medicine and health super-regulator. The treaty to establish an African Medicine Agency (AMA), meant to govern medical product regulation for the entire continent, was endorsed by the African Union Heads of State and Government on 11 February, according to a press release following the 32nd AU Summit in Addis Ababa, Ethiopia. Continue reading -> Mixed Global Progress On Use Of Antibiotics In Animals: OIE Report 01/03/2019 William New There continues to be positive progress on controlling the use of antimicrobials in animals in countries, according to a recent report of the World Organisation for Animal Health (OIE), which is linked to the rise in human antimicrobial resistance. But more countries need to take action and better data is needed from many, the report found, as efforts will continue. Continue reading -> WHO-Led Fair Pricing Forum Registration Opens 01/03/2019 William New Registration has begun for a closed-door gathering allowing governments and stakeholders to hold open discussions about a fairer pricing system for medical products, led by the World Health Organization. The second meeting of the Fair Pricing Forum, this time in South Africa, comes as debates over drug pricing and access rise ever higher in developing and developed countries alike. Continue reading -> Strengthening Supply Chain Security For Essential Antimalarial Drugs 28/02/2019 David Branigan Secure and reliable supply chains for life-saving medicines are essential features of the global health landscape. They ensure that quality approved drugs are manufactured and available in the quantities needed, without interruption. For the fight against malaria, securing supply chains for quality, life-saving antimalarials involves the collective effort of a range of organisations working to mitigate the risk of any shortage of these drugs. A recent success in this area has been the quality approval of a second supplier of injectable artesunate, the drug recommended by the World Health Organization to treat severe malaria. Continue reading -> UN Launches New Strategy On Road Safety For UN Personnel 28/02/2019 David Branigan The United Nations has launched a new road safety strategy to establish a coordinated approach for preventing road traffic crashes, which is a leading cause of death for UN personnel. Continue reading -> Médecins Sans Frontières On Drug Prices – You Can’t Negotiate Blindfolded 27/02/2019 Elaine Ruth Fletcher Katy Athersuch, Médecins Sans Frontières (MSF) Senior Policy Advisor – Medical Innovation & Access, spoke to Health Policy Watch about the recent proposal by Italy’s Minister of Health, Giulia Grillo, for a World Health Assembly resolution on transparency in drug pricing (Health Policy Watch 18 February). The far-reaching proposal asks countries to require disclosure by pharmaceutical companies of their R&D and, manufacturing costs, and public subsidies received, at the time a drug is registered. The resolution would also strengthen WHO’s role in global monitoring and assessment of available data on the costs and pricing of essential medicines. This is the first in a series of Q&As on the issue, looking towards April’s Fair Pricing Forum, where WHO member states will convene in South Africa, followed by the annual World Health Assembly in May. Continue reading -> Global Accelerator Network On Antibacterial Research Expands 26/02/2019 William New A network of life sciences organisations working together to address antibacterial resistance worldwide has expanded to now include 10 top organisations from six countries, according to CARB-X (Combating Antibiotic Resistant Bacteria), a US-based partnership investing hundreds of millions of dollars in R&D for antibacterial resistance over 5 years. Continue reading -> Posts navigation Older postsNewer posts
WHO Announces “Most Wide-Ranging Reforms In Organization’s History” 06/03/2019 Editorial team Calling it a “historic moment,” World Health Organization Director General Tedros Adhanom Gheyebresus today announced wide-ranging reforms in the organization’s structure – claiming they would prove to be the most significant ones in WHO’s 71-year history. Continue reading -> African Heads Of State Endorse Continental Medicine Regulator 06/03/2019 Divya Schlesinger The African content is one step closer to its first medicine and health super-regulator. The treaty to establish an African Medicine Agency (AMA), meant to govern medical product regulation for the entire continent, was endorsed by the African Union Heads of State and Government on 11 February, according to a press release following the 32nd AU Summit in Addis Ababa, Ethiopia. Continue reading -> Mixed Global Progress On Use Of Antibiotics In Animals: OIE Report 01/03/2019 William New There continues to be positive progress on controlling the use of antimicrobials in animals in countries, according to a recent report of the World Organisation for Animal Health (OIE), which is linked to the rise in human antimicrobial resistance. But more countries need to take action and better data is needed from many, the report found, as efforts will continue. Continue reading -> WHO-Led Fair Pricing Forum Registration Opens 01/03/2019 William New Registration has begun for a closed-door gathering allowing governments and stakeholders to hold open discussions about a fairer pricing system for medical products, led by the World Health Organization. The second meeting of the Fair Pricing Forum, this time in South Africa, comes as debates over drug pricing and access rise ever higher in developing and developed countries alike. Continue reading -> Strengthening Supply Chain Security For Essential Antimalarial Drugs 28/02/2019 David Branigan Secure and reliable supply chains for life-saving medicines are essential features of the global health landscape. They ensure that quality approved drugs are manufactured and available in the quantities needed, without interruption. For the fight against malaria, securing supply chains for quality, life-saving antimalarials involves the collective effort of a range of organisations working to mitigate the risk of any shortage of these drugs. A recent success in this area has been the quality approval of a second supplier of injectable artesunate, the drug recommended by the World Health Organization to treat severe malaria. Continue reading -> UN Launches New Strategy On Road Safety For UN Personnel 28/02/2019 David Branigan The United Nations has launched a new road safety strategy to establish a coordinated approach for preventing road traffic crashes, which is a leading cause of death for UN personnel. Continue reading -> Médecins Sans Frontières On Drug Prices – You Can’t Negotiate Blindfolded 27/02/2019 Elaine Ruth Fletcher Katy Athersuch, Médecins Sans Frontières (MSF) Senior Policy Advisor – Medical Innovation & Access, spoke to Health Policy Watch about the recent proposal by Italy’s Minister of Health, Giulia Grillo, for a World Health Assembly resolution on transparency in drug pricing (Health Policy Watch 18 February). The far-reaching proposal asks countries to require disclosure by pharmaceutical companies of their R&D and, manufacturing costs, and public subsidies received, at the time a drug is registered. The resolution would also strengthen WHO’s role in global monitoring and assessment of available data on the costs and pricing of essential medicines. This is the first in a series of Q&As on the issue, looking towards April’s Fair Pricing Forum, where WHO member states will convene in South Africa, followed by the annual World Health Assembly in May. Continue reading -> Global Accelerator Network On Antibacterial Research Expands 26/02/2019 William New A network of life sciences organisations working together to address antibacterial resistance worldwide has expanded to now include 10 top organisations from six countries, according to CARB-X (Combating Antibiotic Resistant Bacteria), a US-based partnership investing hundreds of millions of dollars in R&D for antibacterial resistance over 5 years. Continue reading -> Posts navigation Older postsNewer posts
African Heads Of State Endorse Continental Medicine Regulator 06/03/2019 Divya Schlesinger The African content is one step closer to its first medicine and health super-regulator. The treaty to establish an African Medicine Agency (AMA), meant to govern medical product regulation for the entire continent, was endorsed by the African Union Heads of State and Government on 11 February, according to a press release following the 32nd AU Summit in Addis Ababa, Ethiopia. Continue reading -> Mixed Global Progress On Use Of Antibiotics In Animals: OIE Report 01/03/2019 William New There continues to be positive progress on controlling the use of antimicrobials in animals in countries, according to a recent report of the World Organisation for Animal Health (OIE), which is linked to the rise in human antimicrobial resistance. But more countries need to take action and better data is needed from many, the report found, as efforts will continue. Continue reading -> WHO-Led Fair Pricing Forum Registration Opens 01/03/2019 William New Registration has begun for a closed-door gathering allowing governments and stakeholders to hold open discussions about a fairer pricing system for medical products, led by the World Health Organization. The second meeting of the Fair Pricing Forum, this time in South Africa, comes as debates over drug pricing and access rise ever higher in developing and developed countries alike. Continue reading -> Strengthening Supply Chain Security For Essential Antimalarial Drugs 28/02/2019 David Branigan Secure and reliable supply chains for life-saving medicines are essential features of the global health landscape. They ensure that quality approved drugs are manufactured and available in the quantities needed, without interruption. For the fight against malaria, securing supply chains for quality, life-saving antimalarials involves the collective effort of a range of organisations working to mitigate the risk of any shortage of these drugs. A recent success in this area has been the quality approval of a second supplier of injectable artesunate, the drug recommended by the World Health Organization to treat severe malaria. Continue reading -> UN Launches New Strategy On Road Safety For UN Personnel 28/02/2019 David Branigan The United Nations has launched a new road safety strategy to establish a coordinated approach for preventing road traffic crashes, which is a leading cause of death for UN personnel. Continue reading -> Médecins Sans Frontières On Drug Prices – You Can’t Negotiate Blindfolded 27/02/2019 Elaine Ruth Fletcher Katy Athersuch, Médecins Sans Frontières (MSF) Senior Policy Advisor – Medical Innovation & Access, spoke to Health Policy Watch about the recent proposal by Italy’s Minister of Health, Giulia Grillo, for a World Health Assembly resolution on transparency in drug pricing (Health Policy Watch 18 February). The far-reaching proposal asks countries to require disclosure by pharmaceutical companies of their R&D and, manufacturing costs, and public subsidies received, at the time a drug is registered. The resolution would also strengthen WHO’s role in global monitoring and assessment of available data on the costs and pricing of essential medicines. This is the first in a series of Q&As on the issue, looking towards April’s Fair Pricing Forum, where WHO member states will convene in South Africa, followed by the annual World Health Assembly in May. Continue reading -> Global Accelerator Network On Antibacterial Research Expands 26/02/2019 William New A network of life sciences organisations working together to address antibacterial resistance worldwide has expanded to now include 10 top organisations from six countries, according to CARB-X (Combating Antibiotic Resistant Bacteria), a US-based partnership investing hundreds of millions of dollars in R&D for antibacterial resistance over 5 years. Continue reading -> Posts navigation Older postsNewer posts
Mixed Global Progress On Use Of Antibiotics In Animals: OIE Report 01/03/2019 William New There continues to be positive progress on controlling the use of antimicrobials in animals in countries, according to a recent report of the World Organisation for Animal Health (OIE), which is linked to the rise in human antimicrobial resistance. But more countries need to take action and better data is needed from many, the report found, as efforts will continue. Continue reading -> WHO-Led Fair Pricing Forum Registration Opens 01/03/2019 William New Registration has begun for a closed-door gathering allowing governments and stakeholders to hold open discussions about a fairer pricing system for medical products, led by the World Health Organization. The second meeting of the Fair Pricing Forum, this time in South Africa, comes as debates over drug pricing and access rise ever higher in developing and developed countries alike. Continue reading -> Strengthening Supply Chain Security For Essential Antimalarial Drugs 28/02/2019 David Branigan Secure and reliable supply chains for life-saving medicines are essential features of the global health landscape. They ensure that quality approved drugs are manufactured and available in the quantities needed, without interruption. For the fight against malaria, securing supply chains for quality, life-saving antimalarials involves the collective effort of a range of organisations working to mitigate the risk of any shortage of these drugs. A recent success in this area has been the quality approval of a second supplier of injectable artesunate, the drug recommended by the World Health Organization to treat severe malaria. Continue reading -> UN Launches New Strategy On Road Safety For UN Personnel 28/02/2019 David Branigan The United Nations has launched a new road safety strategy to establish a coordinated approach for preventing road traffic crashes, which is a leading cause of death for UN personnel. Continue reading -> Médecins Sans Frontières On Drug Prices – You Can’t Negotiate Blindfolded 27/02/2019 Elaine Ruth Fletcher Katy Athersuch, Médecins Sans Frontières (MSF) Senior Policy Advisor – Medical Innovation & Access, spoke to Health Policy Watch about the recent proposal by Italy’s Minister of Health, Giulia Grillo, for a World Health Assembly resolution on transparency in drug pricing (Health Policy Watch 18 February). The far-reaching proposal asks countries to require disclosure by pharmaceutical companies of their R&D and, manufacturing costs, and public subsidies received, at the time a drug is registered. The resolution would also strengthen WHO’s role in global monitoring and assessment of available data on the costs and pricing of essential medicines. This is the first in a series of Q&As on the issue, looking towards April’s Fair Pricing Forum, where WHO member states will convene in South Africa, followed by the annual World Health Assembly in May. Continue reading -> Global Accelerator Network On Antibacterial Research Expands 26/02/2019 William New A network of life sciences organisations working together to address antibacterial resistance worldwide has expanded to now include 10 top organisations from six countries, according to CARB-X (Combating Antibiotic Resistant Bacteria), a US-based partnership investing hundreds of millions of dollars in R&D for antibacterial resistance over 5 years. Continue reading -> Posts navigation Older postsNewer posts
WHO-Led Fair Pricing Forum Registration Opens 01/03/2019 William New Registration has begun for a closed-door gathering allowing governments and stakeholders to hold open discussions about a fairer pricing system for medical products, led by the World Health Organization. The second meeting of the Fair Pricing Forum, this time in South Africa, comes as debates over drug pricing and access rise ever higher in developing and developed countries alike. Continue reading -> Strengthening Supply Chain Security For Essential Antimalarial Drugs 28/02/2019 David Branigan Secure and reliable supply chains for life-saving medicines are essential features of the global health landscape. They ensure that quality approved drugs are manufactured and available in the quantities needed, without interruption. For the fight against malaria, securing supply chains for quality, life-saving antimalarials involves the collective effort of a range of organisations working to mitigate the risk of any shortage of these drugs. A recent success in this area has been the quality approval of a second supplier of injectable artesunate, the drug recommended by the World Health Organization to treat severe malaria. Continue reading -> UN Launches New Strategy On Road Safety For UN Personnel 28/02/2019 David Branigan The United Nations has launched a new road safety strategy to establish a coordinated approach for preventing road traffic crashes, which is a leading cause of death for UN personnel. Continue reading -> Médecins Sans Frontières On Drug Prices – You Can’t Negotiate Blindfolded 27/02/2019 Elaine Ruth Fletcher Katy Athersuch, Médecins Sans Frontières (MSF) Senior Policy Advisor – Medical Innovation & Access, spoke to Health Policy Watch about the recent proposal by Italy’s Minister of Health, Giulia Grillo, for a World Health Assembly resolution on transparency in drug pricing (Health Policy Watch 18 February). The far-reaching proposal asks countries to require disclosure by pharmaceutical companies of their R&D and, manufacturing costs, and public subsidies received, at the time a drug is registered. The resolution would also strengthen WHO’s role in global monitoring and assessment of available data on the costs and pricing of essential medicines. This is the first in a series of Q&As on the issue, looking towards April’s Fair Pricing Forum, where WHO member states will convene in South Africa, followed by the annual World Health Assembly in May. Continue reading -> Global Accelerator Network On Antibacterial Research Expands 26/02/2019 William New A network of life sciences organisations working together to address antibacterial resistance worldwide has expanded to now include 10 top organisations from six countries, according to CARB-X (Combating Antibiotic Resistant Bacteria), a US-based partnership investing hundreds of millions of dollars in R&D for antibacterial resistance over 5 years. Continue reading -> Posts navigation Older postsNewer posts
Strengthening Supply Chain Security For Essential Antimalarial Drugs 28/02/2019 David Branigan Secure and reliable supply chains for life-saving medicines are essential features of the global health landscape. They ensure that quality approved drugs are manufactured and available in the quantities needed, without interruption. For the fight against malaria, securing supply chains for quality, life-saving antimalarials involves the collective effort of a range of organisations working to mitigate the risk of any shortage of these drugs. A recent success in this area has been the quality approval of a second supplier of injectable artesunate, the drug recommended by the World Health Organization to treat severe malaria. Continue reading -> UN Launches New Strategy On Road Safety For UN Personnel 28/02/2019 David Branigan The United Nations has launched a new road safety strategy to establish a coordinated approach for preventing road traffic crashes, which is a leading cause of death for UN personnel. Continue reading -> Médecins Sans Frontières On Drug Prices – You Can’t Negotiate Blindfolded 27/02/2019 Elaine Ruth Fletcher Katy Athersuch, Médecins Sans Frontières (MSF) Senior Policy Advisor – Medical Innovation & Access, spoke to Health Policy Watch about the recent proposal by Italy’s Minister of Health, Giulia Grillo, for a World Health Assembly resolution on transparency in drug pricing (Health Policy Watch 18 February). The far-reaching proposal asks countries to require disclosure by pharmaceutical companies of their R&D and, manufacturing costs, and public subsidies received, at the time a drug is registered. The resolution would also strengthen WHO’s role in global monitoring and assessment of available data on the costs and pricing of essential medicines. This is the first in a series of Q&As on the issue, looking towards April’s Fair Pricing Forum, where WHO member states will convene in South Africa, followed by the annual World Health Assembly in May. Continue reading -> Global Accelerator Network On Antibacterial Research Expands 26/02/2019 William New A network of life sciences organisations working together to address antibacterial resistance worldwide has expanded to now include 10 top organisations from six countries, according to CARB-X (Combating Antibiotic Resistant Bacteria), a US-based partnership investing hundreds of millions of dollars in R&D for antibacterial resistance over 5 years. Continue reading -> Posts navigation Older postsNewer posts
UN Launches New Strategy On Road Safety For UN Personnel 28/02/2019 David Branigan The United Nations has launched a new road safety strategy to establish a coordinated approach for preventing road traffic crashes, which is a leading cause of death for UN personnel. Continue reading -> Médecins Sans Frontières On Drug Prices – You Can’t Negotiate Blindfolded 27/02/2019 Elaine Ruth Fletcher Katy Athersuch, Médecins Sans Frontières (MSF) Senior Policy Advisor – Medical Innovation & Access, spoke to Health Policy Watch about the recent proposal by Italy’s Minister of Health, Giulia Grillo, for a World Health Assembly resolution on transparency in drug pricing (Health Policy Watch 18 February). The far-reaching proposal asks countries to require disclosure by pharmaceutical companies of their R&D and, manufacturing costs, and public subsidies received, at the time a drug is registered. The resolution would also strengthen WHO’s role in global monitoring and assessment of available data on the costs and pricing of essential medicines. This is the first in a series of Q&As on the issue, looking towards April’s Fair Pricing Forum, where WHO member states will convene in South Africa, followed by the annual World Health Assembly in May. Continue reading -> Global Accelerator Network On Antibacterial Research Expands 26/02/2019 William New A network of life sciences organisations working together to address antibacterial resistance worldwide has expanded to now include 10 top organisations from six countries, according to CARB-X (Combating Antibiotic Resistant Bacteria), a US-based partnership investing hundreds of millions of dollars in R&D for antibacterial resistance over 5 years. Continue reading -> Posts navigation Older postsNewer posts
Médecins Sans Frontières On Drug Prices – You Can’t Negotiate Blindfolded 27/02/2019 Elaine Ruth Fletcher Katy Athersuch, Médecins Sans Frontières (MSF) Senior Policy Advisor – Medical Innovation & Access, spoke to Health Policy Watch about the recent proposal by Italy’s Minister of Health, Giulia Grillo, for a World Health Assembly resolution on transparency in drug pricing (Health Policy Watch 18 February). The far-reaching proposal asks countries to require disclosure by pharmaceutical companies of their R&D and, manufacturing costs, and public subsidies received, at the time a drug is registered. The resolution would also strengthen WHO’s role in global monitoring and assessment of available data on the costs and pricing of essential medicines. This is the first in a series of Q&As on the issue, looking towards April’s Fair Pricing Forum, where WHO member states will convene in South Africa, followed by the annual World Health Assembly in May. Continue reading -> Global Accelerator Network On Antibacterial Research Expands 26/02/2019 William New A network of life sciences organisations working together to address antibacterial resistance worldwide has expanded to now include 10 top organisations from six countries, according to CARB-X (Combating Antibiotic Resistant Bacteria), a US-based partnership investing hundreds of millions of dollars in R&D for antibacterial resistance over 5 years. Continue reading -> Posts navigation Older postsNewer posts
Global Accelerator Network On Antibacterial Research Expands 26/02/2019 William New A network of life sciences organisations working together to address antibacterial resistance worldwide has expanded to now include 10 top organisations from six countries, according to CARB-X (Combating Antibiotic Resistant Bacteria), a US-based partnership investing hundreds of millions of dollars in R&D for antibacterial resistance over 5 years. Continue reading -> Posts navigation Older postsNewer posts